Basic Searches
Searches without any special characters (listed below) will return items that contain the exact value(s) entered in the search field. This means that searching for "ASPIRIN CALCIUM" won't return any items that have "ASPIRIN GLYCINE CALCIUM" because the search term doesn't match exactly.
Boolean Operators
OR - searches with terms separated by " OR " will return items that contain any of the terms in the search.
Example: "ASPIRIN" OR "CALCIUM" will return items that have strings like "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because they contain at least one of the terms in the search.

AND - searches with terms separated by " AND " will return items that contain all the terms in the search.
Example: "ASPIRIN" AND "CALCIUM" won't return items that have strings "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because neither contain both terms, but it will return "ASPIRIN GLYCINE CALCIUM" because it contains both search terms.
version 2.7.1
Substance Class Protein
Protein Type RECEPTOR
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
EF38T7N5MI
Record Status Validated
Record Version
Show Definitional References Hide Definitional References
Download
Name Type Language Details Access References
GLUCAGON-LIKE PEPTIDE 1 RECEPTOR
Common Name
English  
GLP-1R
Common Name
English  
GLP-1 RECEPTOR
Common Name
English  
Code System Code Type Description Access References
FDA UNII
EF38T7N5MI
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
PRIMARY
PHAROS
P01275
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
PRIMARY
UNIPROT
P01275
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
PRIMARY
From To
1_23 1_48
1_39 1_81
1_62 1_103
1_203 1_273
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_40
N 1_59
N 1_92
Related Record Type Details Access References
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
INHIBITOR -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 04:43:45 EDT 2021 , Edited by admin on Wed Aug 04 04:43:45 EDT 2021
Structural Modifications
Modification Type Location Site Location Type Residue Modified Extent Modification Name Modification ID Access
AMINO ACID SUBSTITUTION [1_318] ADP-RIBOSYLCYSTEINE TES2NDN50T
AMINO ACID SUBSTITUTION [1_325] ADP-RIBOSYLARGININE D5024CP23U
Name Property Type Amount Referenced Substance Defining Parameters Access References
MOL_WEIGHT CHEMICAL
0
Created Wed Aug 04 04:43:45 EDT 2021
Created By admin
Last Edited Wed Aug 04 04:43:45 EDT 2021
Last Edited By admin
Index Source Text / Citation Source Type Tags Date Accessed File Access
1 209637ORIG1S000 NON-CLINICAL REVIEW(S) NDA PUBLIC REVIEW POT
2 UNIPROT UNIPROT NOMEN
3 SRS CODE IMPORT SRS NOMEN Fri Apr 28 15:34:20 EDT 2017
4 ACS 2019 ORLANDO MEETING ABSTRACT PUBLIC_DOMAIN_RELEASE
5 https://en.wikipedia.org/wiki/Exenatide WEBSITE NOMEN
6 https://en.wikipedia.org/wiki/Glucagon-like_peptide-1_receptor_agonist WEBSITE NOMEN
7 PB 1023 WEB PAGE
8 Glucagon-like peptide-1 receptor WIKI POT
9 http://www.uniprot.org/uniprot/P01275 SRS NOMEN
10 PUBCHEM PUBCHEM PUBLIC_DOMAIN_RELEASE NOMEN
11 dump-public-2021-07-22_UPDATED.gsrs BATCH_IMPORT Wed Aug 04 04:43:45 EDT 2021
12 https://en.wikipedia.org/wiki/Taspoglutide WEBSITE NOMEN
13 https://adisinsight.springer.com/drugs/800045287 WEB PAGE
14 PMDA NDA SUPPLEMENTAL DOCUMENTS, SEC. 2.3.2.2.1.1 (IN JAPANESE) PMDA POT
15 Gustavson, S. M., et al. "Effects of a long?acting GLP?1 mimetic (PF?04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitus." Diabetes, Obesity and Metabolism 13.11 (2011): 1056-1058. JA PUBLIC_DOMAIN_RELEASE
16 SRS import [EF38T7N5MI] SRS NOMEN Fri Apr 28 15:34:20 EDT 2017
17 https://en.wikipedia.org/wiki/Albiglutide WEBSITE NOMEN
18 https://en.wikipedia.org/wiki/Dulaglutide WEBSITE NOMEN
19 UniProtKB - P43220 (GLP1R_HUMAN) UNIPROT
20 https://en.wikipedia.org/wiki/Liraglutide WEBSITE NOMEN
21 http://www.uniprot.org/uniprot/P43220 SRS NOMEN PUBLIC_DOMAIN_RELEASE AUTO_SELECTED
22 https://adisinsight.springer.com/drugs/800050497 WEB PAGE
23 https://en.wikipedia.org/wiki/Lixisenatide WEBSITE NOMEN